Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus. (Q45987786)
Jump to navigation
Jump to search
scientific article published on 17 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus. |
scientific article published on 17 April 2009 |
Statements
1 reference
Effects of 4-week treatment with lithium and olanzapine on levels of brain-derived neurotrophic factor, B-cell CLL/lymphoma 2 and phosphorylated cyclic adenosine monophosphate response element-binding protein in the sub-regions of the hippocampus. (English)
1 reference
Michael D Hammonds
1 reference
Seong S Shim
1 reference
17 April 2009
1 reference
105
1 reference
2
1 reference
113-119
1 reference
Identifiers
1 reference